Epistemic Discipline in Psychedelic-Assisted Therapy: Memory, Therapy Dynamics, Attachment Patterns, and Sexual Abuse
Guy Simon, James W. Hopper, Aaron D. Cherniak, Esenia K. Cassidy, Michael Skragge, Pehr Granqvist
Neuroethics December 1, 2026 DOI: 10.1007/s12152-026-09672-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Key points | Argues that psychedelic-assisted therapy carries foreseeable epistemic risks because phenomenological features like noetic quality do not reliably indicate historical veridicality, and that clients with disrupted epistemic trust or histories of sexual abuse may be especially vulnerable. Proposes "epistemic discipline" as a fiduciary clinician obligation across preparation, dosing, and integration, requiring restraint from both endorsing unverifiable material and undermining clients' epistemic agency. |
Abstract
Abstract: Psychedelic-assisted therapy (PAT) is increasingly used for trauma-related disorders, raising ethical questions beyond client safety. We argue that PAT clients have epistemic needs and clinicians have corresponding obligations that call for epistemic humility and discipline, which are essential for regulating foreseeable epistemic risks and for PAT's ethical structure. Drawing on threads of epistemic vulnerability theory, memory research, and emerging empirical evidence on the cognitive and relational effects of psychedelics, we argue that phenomenological characteristics, including noetic quality, are unreliable indicators of historical veridicality and are associated with epistemic risks. Focusing on individual differences associated with attachment patterns and work with sexual abuse survivors, we show how disrupted epistemic trust, authority sensitivity, and structural disempowerment may magnify those epistemic risks. We then develop epistemic discipline as a fiduciary stance that requires restraint in both directions: neither endorsing experiential material as historically veridical when this cannot be established, nor introducing unwarranted doubt that undermines epistemic agency. Because such epistemic vulnerability and its associated risks are foreseeable, if not entirely predictable, we frame epistemic discipline as a fiduciary obligation of the clinician that spans preparation, dosing, and integration, as well as obligations of training programs, credentialing bodies, and professional communities with responsibility to identify and remedy relevant omissions in training and supervision. Finally, we systematize features of epistemic vulnerability and governance mechanisms across PAT phases.
Comparable studies
Other theoretical and historical papers on psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders. | 2024 | Theoretical or philosophical paper | |
| Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance | 2020 | Theoretical or philosophical paper | |
| Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy | 2018 | Theoretical or philosophical paper | |
| Ethical and legal issues in psychedelic harm reduction and integration therapy | 2021 | Theoretical or philosophical paper | |
| Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations. | 2022 | Theoretical or philosophical paper |
Citations in the library
Cites 55
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects. ACS Pharmacology & Translational Science December 10, 2020
and 50 more in the library